Faro, L R F <br/><br/>
Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors.  [electronic resource] 

 -  Neuropharmacology  Apr 2002 
 - 612-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/s0028-3908(02)00009-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Amino-5-phosphonovalerate--pharmacology<br/>Animals<br/>Corpus Striatum--drug effects<br/>Dizocilpine Maleate--pharmacology<br/>Dopamine--biosynthesis<br/>Enzyme Inhibitors--pharmacology<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Female<br/>Methylmercury Compounds--pharmacology<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors